$5M Bet On TreeHouse Foods? Check Out These 3 Stocks Insiders Are Buying

Although U.S. stocks closed higher on Friday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

TreeHouse Foods

• The Trade: TreeHouse Foods, Inc. THS Director Jana Partners LLC acquired a total of 112,275 shares an average price of $44.53. To acquire these shares, it cost around $5 million.
• What’s Happening: TreeHouse Foods announced it will sell its Lakeville manufacturing facility and snack bars business to John B. Sanfilippo & Son for $63 million in cash.
• What TreeHouse Foods Does: TreeHouse Foods, the largest private label manufacturer in the U.S., is the product of a slew of acquisitions, the most significant being the 2016 acquisition of Ralcorp, Conagra's former private brands business.

Burke & Herbert Financial Services

• The Trade: Burke & Herbert Financial Services Corp. BHRB Director Mark G. Anderson acquired a total of 2,400 shares at an average price of $50.00. To acquire these shares, it cost around $120,000.
• What’s Happening: Burke & Herbert Financial Services and Summit Financial Group announced merger of equals.
• What Burke & Herbert Financial Services Does: Burke & Herbert Financial Services Corp is the bank holding company. The bank offers a full range of business and personal financial solutions designed to meet customers' banking, borrowing, and investment needs and has over 20 branches throughout the Northern Virginia region and commercial loan offices in Fredericksburg, Loudoun County, and Richmond, Virginia, and in Bethesda, Maryland.

Don’t forget to check out our premarket coverage here

Mineralys Therapeutics

• The Trade: Mineralys Therapeutics, Inc. MLYS CEO Jon Congleton bought a total of 2,250 shares at an average price of $12.08. To acquire these shares, it cost around $27,180.
• What’s Happening: Mineralys Therapeutics posted a narrower-than-expected quarterly loss.
• What Mineralys Therapeutics Does: Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone.

Check This Out: How To Earn $500 A Month From Smith & Wesson Stock After Upbeat Earnings